Expression of the p53 protein and clinical and pathologic correlation in adenocarcinoma of the rectum

Arquivos de Gastroenterologia

Volumn 43, Issue 1, 2006, Pages 14-19

  Jurach, Márcia Teresinha ^a   Meurer, Luise ^a   Moreira, Luis Fernando ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adenocarcinoma; Protein p53; Rectal neoplasms

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CARCINOMA;

EID: 33646684511     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032006000100006     Document Type: Article

References (28)

1. American Cancer Society. Cancer facts and figures. [cited 2002 Sept 30] Available from: http://www.cancer.org/statistcs.
2. Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE, Taylor GR, Dixon MF, Quirke P. Prognostic value of p53 overexpression and c-ki-ras gene mutations in colorectal cancer. Gastroenterology. 1993;104:57-64.
3. Bosari S, Viale G, Bossi P. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst. 1994;86:681-7.
4. Bosari S, Viale G, Roncalli M, Graziani D, Borsani G, Lee AKC, Doggi G. p53 gene mutations, p54 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol. 1995;147:790-8.
5. The Centers for Disease Control and Prevention. Screening for colorectal cancer: United States, 1997. JAMA. 1999;281:1581-2.
6. Diez M, Medrano M, Muguerza JM, Ramos P, Hernandez P, Villeta R, Martin A, Noguerales F, Ruiz A, Granell J. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas. Anticancer Res. 2000;20(5C):3907-12.
7. Diez M, Enriquez JM, Camunas J. Prediction of recurrence in B-C stages of colorectal cancer by p53 nuclear overexpression in comparison with standard pathological features. Eur J Surg Oncol. 1995;21:635-59.
8. Gallego MG, Acenero MJ, Ortega S, Delgado AA, Cantero JL. Prognostic influence of p53 nuclear overexpression in colorectal carcinoma. Dis Colon Rectum. 2000;43:971-5.
9. Gervaz P, Bouzourene H, Cerottini JP, Chaubert P, Benhattar J, Secic M, Wexner S, Givvel JC, Belin B. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum. 2001;44:364-72.
10. Hertz REL, Deddish MR, Daye E. Value of examination in detecting cancer of the rectum and colon. Postgrad Med. 1960;27:290-4.
11. Kandioler D, Zwrtek R, Ludwig C, Janschek E, Ploner M, Hofbauer F, Kührer I, Kappel S, Wrba F, Horvath M, Karner J, Renner K, Bergmann M, Karner-Hhanusch J, Pötter R, Jakesz R, Teleky B, Herbst F. TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer. Ann Surg. 2002;235:493-8.
12. Khankhanian N, Mauligit GM, RusseL WO. Prognostic significance of vascular invasion in colorectal cancer of Dukes B class. Cancer. 1997;39:1195-200.
13. Kressner U, Lindmar G, Gerdin B. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer. Anticancer Res. 1996;16:951-7.
14. Kressner U, Inganäs M, Bydin S, Blikstad I, Pählman L, Glimelius B, Lindmark G. Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol. 1999;17:593-9.
15. Leahy DT, Salman R, Mucahy, Sheahan K, O'Nonoghue DP, Parfrey NA. Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSP and immunohistochemical analysis. J Pathol. 1996;180:364-70.
16. Maeda K, Chung YS, Kang SM. Overexpression of cyclin D1 and p53 associated with disease recurrence in colorectal adenocarcinoma. Int J Cancer. 1997;74:310-5.
17. Miller SF, Knigth AR. The early detection of colorectal cancer. Cancer. 1997;40:945-9.
18. Moreira LF, Iwagaki H, Hizuta A, Sakagami K, Orita K. Outcome in patients with early colorectal carcinoma. Br J Surg. 1992;79:436-8.
19. Nathanson SD, Linden MD, Tender P. Relationship among p53, stage and prognosis of large bowel cancer. Dis Colon Rectum. 1994;37:527-34.
20. Olson RM, Perencevich NP, Malcom AW, Caffey JT, Wilson RE. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer. 1980;45:2969-74.
21. Pereira H, Silva S, Julião R, Garcia P, Perpétua F. Prognostic markers of colorectal cancer: expression of p53 and Bcl-2. World J Surg. 1997;21:210-3.
22. Ratto C, Sofo L, Ippoliti M, Merico M, Doglietto GB, Crucitti F. Prognostic factors in colorrectal cancer. Literature review for clinical application. Dis Colon Rectum. 1998;41:1033-49.
23. Ribeiro U, Alves VA, Souza PMB, Ribeiro AVS, Rawet V, Nonogaki S, Rodrigues JG, Habr-Gama A. Correlação das proteinas p53 e KI-67 com o prognóstico de pacientes com adenocarcinoma de reto distal. Rev Bras Coloproctol. 2000;20:248-56.
24. Rich T, Gunderson II, Lew R, Galdibini JJ, Cohen AM, Donalsdsib G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer. 1983;52:1317-29.
25. Scwandner O, Schiedeck TH, Bruch HP. Apoptosis in rectal cancer: prognostic significance in comparison with clinical histopathologic, and immunohistochemical variables. Dis Colon Rectum. 2000;43:1227-36.
26. Soong R, Powell B, Elsaleh H, Gnanasampanthan G. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site stage, adjuvant chemotherapy and type of mutation. Eur J Cancer. 2000;36:2053-60.
27. Sun XF, Carstensen JM, Stal O. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma. Virchows Arch A Pathol Anat Histopathol. 1993;423:443-8.
28. Zeng ZS, Sarkis AS, Zhang ZF. p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol. 1994;12:2043-50.